gx-17
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 3, 2019 (NCT04283695)
Timeline
Indications
Mechanism of action
- Interleukin-7Supplementation
Interleukin-7 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05286060 | Phase 2 | May 9, 2022 | Yonsei University |
| NCT04283695 | Early Phase 1 (Phase 1) | Jul 3, 2019 | Seoul National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Yonsei University | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1